Our services:
HEALTH TECHNOLOGY ASSESSMENT
Globally, the reimbursement landscape is constantly evolving. Therapies are generally becoming highly specialized, and more treatments are being developed for rare diseases. The IMAC team have an unparalleled track record for successful reimbursement—read about what IMAC can do for you!
read more
MODELING SERVICES
In the landscape of increasing healthcare costs, strategic economic models have become imperative to successful reimbursement strategy in most markets. IMAC has a highly experienced health economic and outcomes research (HEOR) team that have decades of experience developing innovative economic models—read more about IMAC’s modeling services!
read more
RARE DISEASE SPECIALISTS
Market access in rare disease has unique challenges—limited data, inadequate knowledge base among payers, higher prices, and the lack of dedicated approaches to evaluating rare disease drugs are some of the issues manufacturers face. Read more to see how partnering with the IMAC team who have a deep understanding of market access strategies for rare diseases could help you!
read more
REAL WORLD EVIDENCE
Real-world evidence (RWE) generation continues to be the driver for decision-making by regulators, payers, and providers, and has assumed a progressively greater importance over time to the market access landscape. Read more about how IMAC can help you with RWE.
read more
CANADIAN EXPERTISE
The Canadian market access landscape has become increasingly more complex. Navigating the best path for your therapy can be challenging. We have extensive expertise in the Canadian landscape—read how IMAC can help!
read more
PRIVATE PAYERS
Private payers are a critical part of the market access landscape in Canada and make up a significant percentage of prescription drug purchases. Find out how IMAC can help you navigate this complex market access path!
read moreHow can we help you?
Contact us at one of our International offices or submit a business inquiry online.
Yulia specializes in systematic literature reviews, pharmacoeconomic analyses, and outcomes research.
Why our customers choose us
With IMAC you have access to specialists who will assist you with every challenge on the path to successful reimbursement—we join your team! Here is what IMAC brings to your table:
Expertise
We are a team of experts with decades of industry and consultancy experience that we put to use for you!
Flexibility
The size or our organization allows us to be adaptable, agile, and offer a customized service based on your organizational and project specific needs.
Value
Your goals are our goals. We look to develop a long-lasting partnership. Our business runs on repeat customers who are highly satisfied with our support!
Strategy
We are known for our innovative strategy and finding solutions for even the most challenging problems.
Positive impact
Our goal is to assist you to bring your therapy to patients in need. We believe in the incredible impact of your success in the lives of patients, their families, and the medical profession.
Over the last 17 years, IMAC has worked in numerous therapeutic fields, and we have developed extensive expertise with rare diseases. Collaborating with us, a highly experienced, innovative, and strategic boutique market access firm with a deep understanding of the disease burden in key therapeutic areas, will help you reach and exceed your goals.
Cardiovascular disease
Dermatology
Diabetes
Endocrinology
Gastrointestinal disorders
Haematology
Infectious diseases
Mental health
Metabolic disorder
Nephrology
Neurology
Oncology
Organ transplantation
Reproductive health
Respiratory disorders
Rheumatology
Smoking cessation therapies
Urology
Looking for a first-class market access partner?